Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Targeted patients
View:
Post by canadapiet on Aug 03, 2022 2:13pm

Targeted patients

"This is Theratechnologies’ first-in-human study of TH1902, its investigational lead peptide drug conjugate (“PDC”) linked to docetaxel for the treatment of sortilin-expressing cancers."


So they clearly state a study for "sortilin-expressing cancers" ......., but there are no tools/procedures to measure that?????

OMG
Comment by SPCEO1 on Aug 03, 2022 2:18pm
Ideally, they would have some pre-screening method for sortilin overexpression. Perhaps they will in later trials. I would certainly like to know if my cousin's cancer is overexpressing sortilin as she may be wasting her time if she gets on the trial and she doesn't appear to me to have a lot of time left to waste. Still, they do know there is a high probability the tumors they are testing ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities